Arch Biopartners Inc - ESG Rating & Company Profile powered by AI
This Sustainability assessment for Arch Biopartners Inc indicates its reporting of the United Nations Sustainable Development Goals. If you are employed by Arch Biopartners Inc and you wish to use your ESG aseessment, please contact us. The page is a free Environmental, Social and Governance analysis covering Arch Biopartners Inc.
Arch Biopartners Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Arch Biopartners Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Arch Biopartners Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Arch Biopartners Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Arch Biopartners Inc report the average age of the workforce?
Sign up for free to unlockDoes Arch Biopartners Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Arch Biopartners Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Arch Biopartners Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Arch Biopartners Inc offer flexible work?
Sign up for free to unlockDoes Arch Biopartners Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Arch Biopartners Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Arch Biopartners Inc conduct supply chain audits?
Sign up for free to unlockDoes Arch Biopartners Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Arch Biopartners Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Arch Biopartners Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Arch Biopartners Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Arch Biopartners Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Arch Biopartners Inc disclose water use targets?
Sign up for free to unlockDoes Arch Biopartners Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Arch Biopartners Inc have a product recall in the last two years?
Sign up for free to unlockDoes Arch Biopartners Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Arch Biopartners Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Arch Biopartners Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Arch Biopartners Inc disclose parental leave metrics?
Sign up for free to unlockDoes Arch Biopartners Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Arch Biopartners Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Arch Biopartners Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Arch Biopartners Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Arch Biopartners Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Arch Biopartners Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Arch Biopartners Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Arch Biopartners Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Arch Biopartners Inc disclose its waste policy?
Sign up for free to unlockDoes Arch Biopartners Inc report according to TCFD requirements?
Sign up for free to unlockDoes Arch Biopartners Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Arch Biopartners Inc disclose energy use targets?
Sign up for free to unlockDoes Arch Biopartners Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Arch Biopartners Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Arch Biopartners Inc
These potential risks are based on the size, segment and geographies of the company.
Arch Biopartners Inc., a biotechnology company, develops technologies for medical or commercial impact. It focuses on developing its lead drug candidate Metablok to treat or prevent dipeptidase-1 mediated organ inflammation in the lungs, liver, or kidneys, which results in organ damage or failure, including in the case of sepsis and COVID-19. The company also develops AB569, a drug candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds. In addition, it develops Borg, a peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. The company is based in Toronto, Canada.